116 related articles for article (PubMed ID: 12530692)
1. Role of local 11beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) expression in determining the phenotype of adrenal adenomas.
Mune T; Morita H; Suzuki T; Takahashi Y; Isomura Y; Tanahashi T; Daido H; Yamakita N; Deguchi T; Sasano H; Yasuda K; White PC
Endocr Res; 2002 Nov; 28(4):751-2. PubMed ID: 12530692
[No Abstract] [Full Text] [Related]
2. Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity.
Mazzocchi G; Aragona F; Malendowicz LK; Gottardo L; Nussdorfer GG
J Investig Med; 2001 Mar; 49(2):191-4. PubMed ID: 11288760
[TBL] [Abstract][Full Text] [Related]
3. 11beta-Hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas.
Mazzocchi G; Malendowicz LK; Aragona F; Tortorella C; Gottardo L; Nussdorfer GG
J Investig Med; 2002 Jul; 50(4):288-92. PubMed ID: 12109593
[TBL] [Abstract][Full Text] [Related]
4. Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas.
Mune T; Morita H; Suzuki T; Takahashi Y; Isomura Y; Tanahashi T; Daido H; Yamakita N; Deguchi T; Sasano H; White PC; Yasuda K
J Clin Endocrinol Metab; 2003 Feb; 88(2):864-70. PubMed ID: 12574226
[TBL] [Abstract][Full Text] [Related]
5. 5 -3 -Hydroxysteroid dehydrogenase activity in human adrenal cortical adenomas.
Hoch-Ligeti C
Arch Pathol; 1972 May; 93(5):467-72. PubMed ID: 5020694
[No Abstract] [Full Text] [Related]
6. Human adrenal cortex and aldosterone secreting adenomas express both 11beta-hydroxysteroid dehydrogenase type 1 and type 2 genes.
Albertin G; Tortorella C; Malendowicz LK; Aragona F; Neri G; Nussdorfer GG
Int J Mol Med; 2002 May; 9(5):495-8. PubMed ID: 11956655
[TBL] [Abstract][Full Text] [Related]
7. Histochemistry of 3 beta-hydroxysteroid dehydrogenase in human adrenal cortex in various pathological conditions.
Magrini U; Bertoli G; Mazzola R
Pathol Eur; 1969; 4(1):30-41. PubMed ID: 4305288
[No Abstract] [Full Text] [Related]
8. [The activity of the enzyme systems of steroidogenesis in the adrenals of persons with the Itsenko-Cushing syndrome].
Morozova MS; Razina LG
Probl Endokrinol (Mosk); 1973; 19(4):28-33. PubMed ID: 4788097
[No Abstract] [Full Text] [Related]
9. In vitro on an HCG responsive, testosterone secreting adrenal cortical adenoma.
Pittaway DE; Andersen RN; Givens JR
Steroids; 1973 Dec; 22(6):731-45. PubMed ID: 4149057
[No Abstract] [Full Text] [Related]
10. The in vitro utulization of (4-14C)-dehydroisoandrosterone by human adrenocortical tumors associated with virilism.
Neville AM; Webb JL; Symington T
Steroids; 1969 Jun; 13(6):821-33. PubMed ID: 4239796
[No Abstract] [Full Text] [Related]
11. Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases.
Sandeep TC; Walker BR
Trends Endocrinol Metab; 2001 Dec; 12(10):446-53. PubMed ID: 11701343
[TBL] [Abstract][Full Text] [Related]
12. The role of 11beta-hydroxysteroid dehydrogenase activity in the metabolic syndrome: lessons learned from the animal model.
Dötsch J; Rascher W
Eur J Endocrinol; 2002 May; 146(5):603-5. PubMed ID: 11980613
[No Abstract] [Full Text] [Related]
13. Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy.
Lavery GG; McTernan CL; Bain SC; Chowdhury TA; Hewison M; Stewart PM
Eur J Endocrinol; 2002 Apr; 146(4):553-8. PubMed ID: 11916625
[TBL] [Abstract][Full Text] [Related]
14. Adrenal 11 beta-hydroxysteroid dehydrogenase.
Shimojo M; Condon J; Whorwood CB; Stewart PM
Endocr Res; 1996 Nov; 22(4):771-80. PubMed ID: 8969940
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase.
White PC; Agarwal AK; Nunez BS; Giacchetti G; Mantero F; Stewart PM
Endocr Res; 2000 Nov; 26(4):771-80. PubMed ID: 11196453
[TBL] [Abstract][Full Text] [Related]
16. Expression of 11betaHSD-2 in human adrenal cortical carcinoma and adenoma.
Coulter CL; Smith RE; Stowasser M; Sasano H; Krozowski ZS; Gordon RD
Endocr Res; 1998; 24(3-4):875-6. PubMed ID: 9888591
[No Abstract] [Full Text] [Related]
17. Increased 17 beta-hydroxysteroid dehydrogenase activity in a masculinizing adrenal adenoma in a patient with isolated testosterone overproduction.
Spaulding SW; Masuda T; Osawa Y
J Clin Endocrinol Metab; 1980 Mar; 50(3):537-40. PubMed ID: 6244323
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
20. Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene.
Lavery GG; Ronconi V; Draper N; Rabbitt EH; Lyons V; Chapman KE; Walker EA; McTernan CL; Giacchetti G; Mantero F; Seckl JR; Edwards CR; Connell JM; Hewison M; Stewart PM
Hypertension; 2003 Aug; 42(2):123-9. PubMed ID: 12860834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
